The Phase 2: Collaborative Research and Development project funding aims to enable research and innovate partnerships that progress challenges associated with endemic disease in livestock.

£7.35million has been invested into the Phase 2: CR&D projects to enable co-investment and collaboration between academic researchers, farmers and businesses to reduce overall levels and impact of endemic livestock diseases on the UK livestock sector.

The 14 Phase 2: CR&D projects are:

Genetic and management solutions for lameness-associated endemic diseases in dairy cattle – how do I put contact details under the summary?

Effects of co-infections on Marek’s disease in poultry and development of novel recombinant Marek’s disease virus vector vaccines

Precision solutions for controlling fasciolosis in sheep.

Next generation vaccines for bovine respiratory disease (BRD) complex utilizing virus vaccine vectors to target both bacterial and viral pathogens.

Monitoring the gut microbiome via AI and omics: a new approach to detect infection and AMR and to support novel therapeutics in broiler precision farms

Forestry by products as novel therapeutics for parasite control in livestock

Delivery of rapid diagnostic tests for sustainable control of parasitic diseases in sheep and cattle

Genetic and management solutions for lameness-associated endemic diseases in dairy cattle

Protecting pigs from enzootic pneumonia: Rational design of safe attenuated vaccines

AI to monitor changes in social behaviour for the early detection of disease in dairy cattle

Unravelling the Aetiology of Stunting in UK Broiler Flocks through the use of novel Microdissection and Viral Metatranscriptomics Sequencing Tools